Among older adults with at least two chronic conditions but no known cardiovascular disease, discontinuing statin therapy was noninferior to…
In a large randomized trial, atorvastatin 40 mg daily significantly reduced major cardiovascular events by 30% among community-dwelling adults aged…
In adults aged 75 years or older without a history of atherosclerotic cardiovascular disease (ASCVD) who were taking statins for…
To address uncertainties in statin safety profiles, which are often based on observational data susceptible to bias, researchers conducted a…
A Chinese sequential target trial emulation comparing matched cohorts initiating versus not initiating statin therapy suggested benefits and safety of…
This website uses cookies.